Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Financials | 2.23% |
| 4 | Healthcare | 2.22% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Elanco Animal Health
ELAN
$11.2B
| $44.4M | 0.01% |
1,390,983
-66,675
| -5% | -$2.24M |
|
1177
Northern Trust
NTRS
$35B
| $44.3M | 0.01% |
+411,143
| New | +$46.7M |
|
1178
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.41B
| $44.2M | 0.01% |
413,400
-35,500
| -8% | -$4.12M |
|
1179
CALL
Crocs
CROX
$6.36B
| $44.2M | 0.01% |
308,000
+140,500
| +84% | +$19.3M |
|
1180
Air Products & Chemicals
APD
$67.7B
| $44.1M | 0.01% |
172,322
+106,495
| +162% | +$29.5M |
|
1181
Casey's General Stores
CASY
$31B
| $44.1M | 0.01% |
234,077
+223,906
| +2,201% | +$43.9M |
|
1182
Houlihan Lokey
HLI
$9.24B
| $44.1M | 0.01% |
478,607
+380,388
| +387% | +$33.3M |
|
1183
CALL
Kraft Heinz
KHC
$30.1B
| $44.1M | 0.01% |
1,197,100
+444,800
| +59% | +$16.7M |
|
1184
iShares MSCI Taiwan ETF
EWT
$11.6B
| $44.1M | 0.01% |
+710,476
| New | +$45.3M |
|
1185
Affirm
AFRM
$26.2B
| $44M | 0.01% |
368,937
-429,745
| -54% | -$34.3M |
|
1186
CALL
NetEase
NTES
$78.5B
| $43.9M | 0.01% |
514,500
+295,300
| +135% | +$27.9M |
|
|
ITCI
1187
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $43.9M | 0.01% |
1,176,465
-384,927
| -25% | -$13.4M |
|
|
FVIV
1188
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
| $43.8M | 0.01% |
4,501,474
+1,999,996
| +80% | +$19.5M |
|
|
SAIL
1189
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $43.8M | 0.01% |
1,021,369
+415,813
| +69% | +$19.7M |
|
1190
CALL
Zoetis
ZTS
$31.3B
| $43.7M | 0.01% |
224,900
+56,700
| +34% | +$11.4M |
|
1191
CALL
Nasdaq
NDAQ
$54.6B
| $43.6M | 0.01% |
678,300
+394,500
| +139% | +$24.8M |
|
1192
ProShares UltraPro QQQ
TQQQ
$38.7B
| $43.6M | 0.01% |
1,399,744
+1,098,944
| +365% | +$37.6M |
|
1193
Interactive Brokers
IBKR
$41.4B
| $43.5M | 0.01% |
2,790,972
+283,780
| +11% | +$4.47M |
|
1194
PUT
Stryker
SYK
$131B
| $43.5M | 0.01% |
164,800
+2,600
| +2% | +$695K |
|
|
1195
PUT
NetEase
NTES
$78.5B
| $43.3M | 0.01% |
506,800
+224,100
| +79% | +$21.2M |
|
1196
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $43.3M | 0.01% |
+857,049
| New | +$44.6M |
|
1197
Bristol-Myers Squibb
BMY
$132B
| $43M | 0.01% |
727,059
-1,332,962
| -65% | -$87.8M |
|
1198
iShares MSCI Switzerland ETF
EWL
$2.22B
| $43M | 0.01% |
923,194
+388,522
| +73% | +$19.3M |
|
1199
Knight Transportation
KNX
$11.9B
| $43M | 0.01% |
840,435
+746,973
| +799% | +$37.6M |
|
1200
CALL
Crown Castle
CCI
$31.5B
| $43M | 0.01% |
247,900
-17,100
| -6% | -$3.31M |
|
Similar funds
Ken Griffin's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.